Home Business Today’s stock market 0506丨Can A-shares shrink to resist short-term resilience amid the sharp decline in the periphery?

Today’s stock market 0506丨Can A-shares shrink to resist short-term resilience amid the sharp decline in the periphery?

by admin
Today’s stock market 0506丨Can A-shares shrink to resist short-term resilience amid the sharp decline in the periphery?

today’s feed

[Topic]A-shares shrink and resist due to the sharp decline in the periphery, can they show resilience in the short term?

[Topic]Some software stocks have rebounded sharply. Is there a chance?

[Viewpoint]Cai Lingling: The weight is negative, and the ChiNext is expected to stabilize.

[Viewpoint]Chen Wen: The performance of the disk is quite differentiated, and the bearish atmosphere still needs to be gradually resolved.

[Viewpoint]Wu Hairong: Focus on pesticides, fertilizers and consumption sectors on dips.

Review today

The index was adjusted across the board. The Shanghai index closed at 3001.56, a decrease of 2.16%. Can it show resilience in the short term? The ChiNext opened lower for two consecutive days and then rebounded. The Component Index closed at 2244.97, down 1.90%. Is the buying power below showing?

In terms of sectors, sectors such as smart government affairs and smart medical care rose against the market trend, while sectors such as hotel and catering, real estate, and tourism were among the top decliners.

The transaction volume of the three cities was 760.2 billion, and the volume could shrink sharply. Is the selling pressure weakening or a strong wait-and-see mood? The market sentiment has dropped, more than 3,300 stocks fell, 85 stocks rose by the limit, and 12 stocks fell by the limit. The profit-making effect is only 27%. The index is repeatedly low. How to operate in the short term?

On the disk, some software stocks rebounded sharply, and many stocks such as 2345, Inspur Software, and China Software have daily limit. Is there any chance? Pharmaceutical and medical stocks are repeatedly active. Haichen Pharmaceutical, China Pharmaceutical, Fudan Fuhua, Yongan Pharmaceutical and other over 20 stocks are closed. Which opportunities are worth paying attention to? The real estate sector has undergone major adjustments, and Hualian Holdings, China Enterprises, China Wuyi, etc. have fallen to the limit. What do you think?

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy